Posted at 14:48h
On November 22nd
, 2019, we will be hosting an R&D Day in New York City. The event will showcase Alnylam’s late stage clinical efforts, next wave programs, and platform advances. The Company will also discuss its perspective on its transition toward achieving a self-sustainable financial profile.
To view the webcast, click here. A replay of the webcast will be available at that link on November 23rd.
To view the R&D Day Presentation, click here